Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from CAH

What You Need To Know Ahead of Cardinal Health's Earnings Release

Cardinal Health is scheduled to announce its third-quarter results next month, with analysts anticipating a single-digit earnings growth.

Barchart

Cardinal Health Has a String of New Highs

Summary Cardinal Health (CAH) shows strong technical buy signals, with a 3.95% gain since the Trend Seeker buy signal on 3/18 and consistent price appreciation. The company operates globally, providing a wide range of healthcare services and products, including pharmaceuticals, medical supplies, and radiopharmaceuticals. Barchart's technical indicators highlight CAH's positive...

Barchart

Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector?

Cardinal Health has surpassed the broader healthcare sector’s performance over the past year, and analysts are expressing continued confidence in its growth potential.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Healthtech Stocks Making Healthcare More Accessible

The healthcare market is fueling digital transformation by improving efficiency and fostering personalized care, making it an attractive investment opportunity. Hence, investors might consider investing in healthcare stocks, such as Teladoc Health (TDOC), Zimmer Biomet Holdings (ZBH), and Cardinal Health (CAH). Read more….

StockNews.com

Are Wall Street Analysts Predicting Cardinal Health Stock Will Climb or Sink?

Cardinal Health has observed a notable surge in stock prices recently and received several ratings upgrades shifting the consensus to a "Strong Buy."

Barchart

What to Expect From Cardinal Health's Next Quarterly Earnings Report

Cardinal Health is expected to release its fiscal 2025 second-quarter earnings this month, and analysts project a single-digit profit decline.

Barchart

Is Cardinal Health Stock Underperforming the Dow?

Cardinal Health has underperformed the Dow Jones Industrial Average over the past year, yet analysts remain optimistic about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

3 Dividend Aristocrats With Consistent Payouts

Dividend aristocrats are known for their market resilience, and regular dividend increases, benefitting investors. Hence, investing in fundamentally sound dividend aristocrat stocks Emerson Electric (EMR), Cardinal Health (CAH), and Dover (DOV) could be wise for consistent payouts. Read more.

StockNews.com

Is Wall Street Bullish or Bearish on Cardinal Health Stock?

Although Cardinal Health has underperformed relative to the broader S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart

3 Undervalued Health-Tech Stocks to Buy for Long-Term Growth

The health-tech industry’s long-term growth is fueled by the growing need for cutting-edge technologies to address critical areas, as well as the demand for personalized medicine. Thus, it could be wise to invest in fundamentally solid health-tech stocks McKesson (MCK), Cardinal Health (CAH), and Zimmer Biomet (ZBH) poised for long-term…

StockNews.com

What to Expect From Cardinal Health's Q1 2025 Earnings Report

Cardinal Health is expected to release its fiscal first-quarter earnings next month, and analysts project a single-digit profit decline.

Barchart

3 Value Stocks to Buy Now Before Wall Street Catches On

Investing in value stocks is appealing now due to their strong long-term performance and affordability, as interest rates decline and inflation stabilizes, providing a lower-risk opportunity before Wall Street takes notice. Hence, it may be wise to add fundamentally strong value stocks like Stellantis (STLA), Centene (CNC), and Cardinal Health…

StockNews.com

Why Is Viral 'Cards Against Humanity' Suing Elon Musk's SpaceX For $15M? What You Need To Know

Cards Against Humanity, the irreverent card game, has sued Elon Musk's SpaceX over alleged property encroachment at the company's Starbase facility in Texas.

International Business Times UK

Cards Against Humanity Sues Elon Musk’s SpaceX For Trespassing Land: ‘Go F*ck Yourself’

The beloved, but chaotic card game Cards Against Humanity is suing Elon Musk and I fear the lawsuit is pretty iconic. Here are all the deets!

Pedestrian.tv

Get all your
news in one place.

100’s of premium titles.
One news app.

Space

Cards Against Humanity sues SpaceX for $15 million over land dispute

Cards Against Humanity is suing SpaceX for $15 million because the rocket company allegedly damaged land that CAH owns.

Latin Times

Elon Musk Sued for Millions by Card Game for Trespassing on Texas Land They Purchased to Prevent Trump from Building Wall

Cards Against Humanity is suing Elon Musk for allowing SpaceX to dump their "sh*t" all over their "gorgeous plot of land without asking."

PC Gamer

Cards Against Humanity sues Elon Musk for $15M, alleges that SpaceX invaded a plot of land it owns in Texas: 'Go **** yourself, Elon Musk'

If it wins, the card game company says it'll split the money among the backers who crowdfunded the land purchase in 2017.

Barchart

Is Cardinal Health Stock Underperforming the Nasdaq?

Despite Cardinal Health’s underperformance relative to the Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Cardinal Health Clears Buy Point On Bullish Fiscal 2025 View

Cardinal Health reported better-than-expected fiscal fourth-quarter earnings and hiked 2025 profit expectations

Barchart

Stock Index Futures Tread Water as Key U.S. Inflation Data Looms

September S&P 500 E-Mini futures (ESU24) are up +0.02%, and September Nasdaq 100 E-Mini futures (NQU24) are down -0.09% this morning as market participants held back from making any big bets ahead of the release of the U.S. consumer inflation report.

Barchart

Are Wall Street Analysts Bullish on Cardinal Health Stock?

Cardinal Health has underperformed the broader market over the past year, but Wall Street analysts are moderately bullish about the stock’s prospects.

Barchart

Here's What to Expect From Cardinal Health's Next Earnings Report

Cardinal Health is all set to announce its fourth-quarter results next month, and analysts are projecting double-digit earnings growth.

StockNews.com

3 Growth Stocks With P/E Ratios Below Industry Average

Growth stocks trading at lower P/E ratio than the industry average can be a suitable investment choice. Top picks now could be Cardinal Health (CAH), Baxter International (BAX), and DocuSign (DOCU). Keep reading.

Barchart

How Is McKesson's Stock Performance Compared to Other Healthcare Stocks?

McKesson has outperformed other healthcare stocks over the past three months, and analysts remain optimistic about the stock’s prospects.

Barchart

What Are Wall Street Analysts' Target Price for Cardinal Health Stock?

Cardinal Health’s shares have underperformed the broader market over the past year, yet Wall Street analysts maintain a cautiously optimistic outlook on the stock.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Chipotle Mexican Grill

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.